Shuangjia Wang

894 total citations
19 papers, 615 citations indexed

About

Shuangjia Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shuangjia Wang has authored 19 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Shuangjia Wang's work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer Mechanisms and Therapy (3 papers) and RNA modifications and cancer (3 papers). Shuangjia Wang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Cancer Mechanisms and Therapy (3 papers) and RNA modifications and cancer (3 papers). Shuangjia Wang collaborates with scholars based in China, United States and New Zealand. Shuangjia Wang's co-authors include Bei Sun, Shangha Pan, Hongchi Jiang, Yongwei Wang, Rui Kong, Zhuoxin Cheng, Xuewei Bai, Yue Gao, Yinan Zhou and Dongbo Xue and has published in prestigious journals such as PLoS ONE, Cancer Letters and Biomedicine & Pharmacotherapy.

In The Last Decade

Shuangjia Wang

19 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuangjia Wang China 13 333 242 217 106 52 19 615
Qixing Tan China 13 224 0.7× 166 0.7× 192 0.9× 94 0.9× 68 1.3× 33 570
Y C Wong Hong Kong 13 385 1.2× 223 0.9× 165 0.8× 79 0.7× 57 1.1× 14 681
Zhuoxin Cheng China 14 280 0.8× 156 0.6× 159 0.7× 62 0.6× 49 0.9× 20 557
Hao Deng China 16 277 0.8× 162 0.7× 108 0.5× 57 0.5× 36 0.7× 71 635
Khurum Khan United Kingdom 10 289 0.9× 226 0.9× 128 0.6× 49 0.5× 50 1.0× 28 567
Stephen P. Fink United States 17 646 1.9× 256 1.1× 292 1.3× 66 0.6× 109 2.1× 31 1.1k
Jue Yang China 18 557 1.7× 203 0.8× 269 1.2× 96 0.9× 73 1.4× 60 933
Atena Soleimani Iran 15 417 1.3× 186 0.8× 229 1.1× 62 0.6× 89 1.7× 31 736
Marie Ehrlichová Czechia 15 391 1.2× 335 1.4× 160 0.7× 63 0.6× 45 0.9× 27 687

Countries citing papers authored by Shuangjia Wang

Since Specialization
Citations

This map shows the geographic impact of Shuangjia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuangjia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuangjia Wang more than expected).

Fields of papers citing papers by Shuangjia Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuangjia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuangjia Wang. The network helps show where Shuangjia Wang may publish in the future.

Co-authorship network of co-authors of Shuangjia Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shuangjia Wang. A scholar is included among the top collaborators of Shuangjia Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuangjia Wang. Shuangjia Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Wang, Shuangjia, et al.. (2024). C-FOS inhibition promotes pancreatic cancer cell ferroptosis by transcriptionally regulating the expression of SLC7A11. Functional & Integrative Genomics. 24(5). 163–163. 1 indexed citations
3.
Wang, Chunyue, et al.. (2021). Long non‐coding RNA DUXAP9 promotes hepatocellular carcinoma cell stemness via directly interacting with sox9. Environmental Toxicology. 36(9). 1793–1801. 11 indexed citations
4.
Pang, Yizhen, Long Zhao, Qihang Shang, et al.. (2021). Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer. European Journal of Nuclear Medicine and Molecular Imaging. 49(4). 1322–1337. 75 indexed citations
5.
Wang, Shuangjia, et al.. (2020). MicroRNA-202 suppresses glycolysis of pancreatic cancer by targeting hexokinase 2. Journal of Cancer. 12(4). 1144–1153. 18 indexed citations
6.
Zhang, Wenqing, et al.. (2019). Upregulation of DPY30 promotes cell proliferation and predicts a poor prognosis in cholangiocarcinoma. Biomedicine & Pharmacotherapy. 123. 109766–109766. 14 indexed citations
7.
Wu, Qiu-Wan, et al.. (2017). SYPL1 overexpression predicts poor prognosis of hepatocellular carcinoma and associates with epithelial-mesenchymal transition. Oncology Reports. 38(3). 1533–1542. 16 indexed citations
8.
Xu, Meihong, et al.. (2015). Anti-rheumatoid arthritic effects of Saussurea involucrata on type II collagen-induced arthritis in rats. Food & Function. 7(2). 763–770. 15 indexed citations
9.
Wang, Shuangjia, et al.. (2014). Embryotoxicity of Transgenic Rice TT51 and Cry1Ab Bt Insecticidal Toxin in Rat Post Implantation Whole Embryo Culture. Journal of Food and Nutrition Research. 2(3). 115–121. 1 indexed citations
10.
Cheng, Zhuoxin, et al.. (2012). [Experimental study of the function of nuclear factor-κB-dependent epithelial to mesenchymal transition in pancreatic cancer cells under hypoxic conditions].. PubMed. 50(5). 446–51. 3 indexed citations
11.
Wang, Yongwei, Shuangjia Wang, Yinan Zhou, Shangha Pan, & Bei Sun. (2012). Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo. Journal of Cancer Research and Clinical Oncology. 138(5). 785–797. 72 indexed citations
12.
13.
Kong, Rui, Guang Jia, Zhuoxin Cheng, et al.. (2012). Dihydroartemisinin Enhances Apo2L/TRAIL-Mediated Apoptosis in Pancreatic Cancer Cells via ROS-Mediated Up-Regulation of Death Receptor 5. PLoS ONE. 7(5). e37222–e37222. 64 indexed citations
14.
Cheng, Zhuoxin, Bei Sun, Shuangjia Wang, et al.. (2011). Nuclear Factor-κB–Dependent Epithelial to Mesenchymal Transition Induced by HIF-1α Activation in Pancreatic Cancer Cells under Hypoxic Conditions. PLoS ONE. 6(8). e23752–e23752. 76 indexed citations
15.
Wang, Shuangjia, Bei Sun, Zhuoxin Cheng, et al.. (2011). Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway. Cancer Chemotherapy and Pharmacology. 68(6). 1421–1430. 70 indexed citations
16.
Zhou, Yanming, et al.. (2011). Does External Pancreatic Duct Stent Decrease Pancreatic Fistula Rate after Pancreatic Resection? A Meta-Analysis. Pancreatology. 11(3). 362–370. 33 indexed citations
17.
Wang, Shuangjia, Bei Sun, Shangha Pan, et al.. (2010). [Experimental study of the function and mechanism combining dihydroartemisinin and gemcitabine in treating pancreatic cancer].. PubMed. 48(7). 530–4. 9 indexed citations
18.
Kong, Rui, Bei Sun, Hongchi Jiang, et al.. (2009). Downregulation of nuclear factor-κB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer. Cancer Letters. 291(1). 90–98. 72 indexed citations
19.
Chen, Ping, Bei Sun, Hua Chen, et al.. (2009). Effects of carbon monoxide releasing molecule-liberated CO on severe acute pancreatitis in rats. Cytokine. 49(1). 15–23. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qixing Tan Breakdown of academic impact, for papers by Y C Wong Breakdown of academic impact, for papers by Zhuoxin Cheng Breakdown of academic impact, for papers by Hao Deng Breakdown of academic impact, for papers by Khurum Khan Breakdown of academic impact, for papers by Stephen P. Fink Breakdown of academic impact, for papers by Jue Yang Breakdown of academic impact, for papers by Atena Soleimani Breakdown of academic impact, for papers by Marie Ehrlichová
Rankless by CCL
2026